BIOLOGICAL EFFECTS OF DISRUPTION OF THE TISSUE-TYPE PLASMINOGEN-ACTIVATOR, UROKINASE-TYPE PLASMINOGEN-ACTIVATOR, AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 GENES IN MICE

被引：0
作者：
CARMELIET, P
BOUCHE, A
DECLERCQ, C
JANSSEN, S
POLLEFEYT, S
WYNS, S
MULLIGAN, RC
COLLEN, D
机构：
[1] CATHOLIC UNIV LEUVEN,CTR MOLEC & VASC BIOL,B-3000 LOUVAIN,BELGIUM
[2] MIT,DEPT BIOL,CAMBRIDGE,MA
[3] MIT,WHITEHEAD INST BIOMED RES,CAMBRIDGE,MA
来源：
ATHEROSCLEROSIS III: RECENT ADVANCES IN ATHEROSCLEROSIS RESEARCH: THE THIRD SARATOGA INTERNATIONAL CONFERENCE ON ATHEROSCLEROSIS IN NEKOMA | 1995年 / 748卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：367 / 382
页数：16
相关论文
共 22 条
[1]  
ASTRUF T, 1978, PROGR CHEM FIBRINOLY
[2]  
BAKER MS, 1990, CANCER RES, V50, P4676
[3]   CLONING, NUCLEOTIDE SEQUENCING AND EXPRESSION OF CDNAS ENCODING MOUSE UROKINASE-TYPE PLASMINOGEN-ACTIVATOR [J].
BELIN, D ;
VASSALLI, JD ;
COMBEPINE, C ;
GODEAU, F ;
NAGAMINE, Y ;
REICH, E ;
KOCHER, HP ;
DUVOISIN, RM .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1985, 148 (02) :225-232
[4]   UROKINASE-TYPE PLASMINOGEN-ACTIVATOR - PROENZYME, RECEPTOR, AND INHIBITORS [J].
BLASI, F ;
VASSALLI, JD ;
DANO, K .
JOURNAL OF CELL BIOLOGY, 1987, 104 (04) :801-804
[5]   PHYSIOLOGICAL CONSEQUENCES OF LOSS OF PLASMINOGEN-ACTIVATOR GENE-FUNCTION IN MICE [J].
CARMELIET, P ;
SCHOONJANS, L ;
KIECKENS, L ;
REAM, B ;
DEGEN, J ;
BRONSON, R ;
DEVOS, R ;
VANDENOORD, JJ ;
COLLEN, D ;
MULLIGAN, RC .
NATURE, 1994, 368 (6470) :419-424
[6]   PLASMINOGEN-ACTIVATOR INHIBITOR-1 GENE DEFICIENT MICE .2. EFFECTS ON HEMOSTASIS, THROMBOSIS, AND THROMBOLYSIS [J].
CARMELIET, P ;
STASSEN, JM ;
SCHOONJANS, L ;
REAM, B ;
VANDENOORD, JJ ;
DEMOL, M ;
MULLIGAN, RC ;
COLLEN, D .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (06) :2756-2760
[7]   PLASMINOGEN-ACTIVATOR INHIBITOR-1 GENE DEFICIENT MICE .1. GENERATION BY HOMOLOGOUS RECOMBINATION AND CHARACTERIZATION [J].
CARMELIET, P ;
KIECKENS, L ;
SCHOONJANS, L ;
REAM, B ;
VANNUFFELEN, A ;
PRENDERGAST, G ;
COLE, M ;
BRONSON, R ;
COLLEN, D ;
MULLIGAN, RC .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (06) :2746-2755
[8]  
COLLEN D, 1991, BLOOD, V78, P3114
[9]   PLASMINOGEN ACTIVATORS, TISSUE DEGRADATION, AND CANCER [J].
DANO, K ;
ANDREASEN, PA ;
GRONDAHLHANSEN, J ;
KRISTENSEN, P ;
NIELSEN, LS ;
SKRIVER, L .
ADVANCES IN CANCER RESEARCH, 1985, 44 :139-266
[10]   BRIEF REPORT - COMPLETE DEFICIENCY OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 DUE TO A FRAME-SHIFT MUTATION [J].
FAY, WP ;
SHAPIRO, AD ;
SHIH, JL ;
SCHLEEF, RR ;
GINSBURG, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (24) :1729-1733
123